Impact of Interferon Beta on Quality of Life in Multiple Sclerosis Patients
Author Information
Author(s): Simone Isabella Laura, Ceccarelli Antonia, Tortorella Carla, Bellacosa Alessandra, Pellegrini Fabio, Plasmati Immacolata, De Caro Maria Fara, Lopez Mariangela, Girolamo Francesco, Livrea Paolo
Primary Institution: Department of Neurological and Psychiatric Sciences, University of Bari, Italy
Hypothesis
Does Interferon-beta treatment influence the quality of life in multiple sclerosis patients over time?
Conclusion
Interferon-beta treatment negatively impacted the quality of life over time, particularly affecting mental well-being.
Supporting Evidence
- Patients treated with IFN-β showed a younger age and lower disease duration compared to untreated patients.
- After two years, mental health scores significantly decreased in the IFN-β treated group.
- Depression and fatigue were significant predictors of poor quality of life.
Takeaway
This study found that taking a specific medicine for multiple sclerosis can make people feel worse over time, especially in their feelings and mood.
Methodology
A non-randomized study evaluated 127 MS patients, comparing quality of life before and after two years of treatment using the MSQoL-54 questionnaire.
Potential Biases
Potential bias due to the non-randomized design and the exclusion of patients who started treatment during the study.
Limitations
The study had a relatively short follow-up period and a significant number of patients did not complete the follow-up questionnaire.
Participant Demographics
The study included 127 MS patients, with a higher prevalence of relapsing-remitting course and a majority being female.
Statistical Information
P-Value
p = 0.006 for mental health composite score changes
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website